IDT Biologika @ Outsourced Pharma Capacity Update – Fill-Finish Session – April 2025

For more than three decades we are working in the commercial filling of biologics and small molecules, such as vaccines, proteins, monoclonal antibodies, biosimilars for leading multinational companies. As end-to-end service provider and with a combination of world-class manufacturing solutions and process excellence, we support you to bring your therapies with the highest quality and speed to market.

In this webinar you will learn more about:

– Our End-to-End Services covering vials (incl. Lyo) and syringes (PFS)
– Our range of fill-finish offerings, including our high-speed filling line for vials
– How strategic investments in new technologies allow us to meet the growing industry need for global sterile fill-finish solutions
– How we handle the various entry points for customer projects at IDT Biologika

<br>